| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
| SN. |
Smith & Nephew
|
FTSE 100
| 2.28 |
£10.73B
| 1,248.50 | -1.23% |
| CTEC |
ConvaTec Group
|
FTSE 100
| 2.03 |
£4.9B
| 245.80 | -1.13% |
| SPI |
Spire Healthcare Group
|
FTSE 250
| 1.02 |
£906.21M
| 225.00 | 0.00% |
| UPR |
Uniphar
|
AIM
| 0.01 |
£892.94M
| 336.12 | 0.90% |
| AMS |
Advanced Medical Solutions Group
|
AIM
| 1.24 |
£466.73M
| 212.50 | 3.10% |
| NIOX |
Niox Group
|
AIM
| 1.78 |
£294.18M
| 69.60 | |
| TSTL |
Tristel
|
Main Market
| 3.84 |
£176.66M
| 375.00 | 1.60% |
| EKF |
EKF Diagnostics Holdings
|
AIM
| |
£114.95M
| 25.80 | 1.00% |
| SPEC |
Inspecs Group
|
AIM
| |
£73.2M
| 73.00 | -0.30% |
| SDI |
SDI Group
|
AIM
| |
£72.66M
| 69.00 | -1.50% |
| KMK |
Kromek Group
|
AIM
| |
£46.5M
| 7.10 | 8.70% |
| CREO |
Creo Medical Group
|
AIM
| |
£43.27M
| 10.60 | -0.80% |
| NCYT |
Novacyt SA
|
AIM
| |
£27.4M
| 39.03 | 4.20% |
| IHC |
Inspiration Healthcare Group
|
AIM
| |
£18.16M
| 19.87 | 0.60% |
| FAB |
Fusion Antibodies
|
AIM
| |
£14.21M
| 12.80 | 25.90% |
| COG |
Cambridge Cognition Holdings
|
AIM
| |
£13.82M
| 32.00 | -0.40% |
| RUA |
RUA Life Sciences
|
AIM
| |
£7.76M
| 12.40 | -6.90% |
| GENI |
Genincode
|
AIM
| |
£7.17M
| 2.22 | 1.40% |
| SUN |
Surgical Innovations Group
|
AIM
| |
£5.36M
| 0.57 | -2.30% |
| MHC |
MyHealthChecked
|
AIM
| |
£4.55M
| 8.75 | 5.30% |
| BELL |
Belluscura
|
AIM
| |
£3.01M
| 0.75 | -1.10% |
| POLX |
Polarean Imaging
|
AIM
| |
£1.75M
| 0.11 | -3.20% |
| PYC |
Physiomics
|
AIM
| |
£1.27M
| 0.39 | -3.80% |
| TLY |
Totally
|
AIM
| |
–
| 0.24 | -1.90% |
| TRLS |
Trellus Health
|
AIM
| |
–
| 0.52 | 7.30% |